A detailed history of Exane Derivatives transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Exane Derivatives holds 43 shares of HCAT stock, worth $296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 43 -0.0%
Holding current value
$296
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$36.68 - $54.02 $73 - $108
-2 Reduced 4.44%
43 $1,000
Q2 2021

Jul 28, 2021

SELL
$47.17 - $58.64 $2,028 - $2,521
-43 Reduced 48.86%
45 $2,000
Q1 2021

Apr 30, 2021

BUY
$42.51 - $54.07 $552 - $702
13 Added 17.33%
88 $4,000
Q4 2020

Jan 27, 2021

BUY
$31.9 - $44.89 $2,392 - $3,366
75 New
75 $3,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.